These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 16177248)

  • 1. Autoantibody signatures in prostate cancer.
    Wang X; Yu J; Sreekumar A; Varambally S; Shen R; Giacherio D; Mehra R; Montie JE; Pienta KJ; Sanda MG; Kantoff PW; Rubin MA; Wei JT; Ghosh D; Chinnaiyan AM
    N Engl J Med; 2005 Sep; 353(12):1224-35. PubMed ID: 16177248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer immunomics: using autoantibody signatures in the early detection of prostate cancer.
    Bradford TJ; Wang X; Chinnaiyan AM
    Urol Oncol; 2006; 24(3):237-42. PubMed ID: 16678056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum-autoantibodies for discovery of prostate cancer specific biomarkers.
    Massoner P; Lueking A; Goehler H; Höpfner A; Kowald A; Kugler KG; Amersdorfer P; Horninger W; Bartsch G; Schulz-Knappe P; Klocker H
    Prostate; 2012 Mar; 72(4):427-36. PubMed ID: 22012634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of autoantibody signatures as biomarkers for early detection of colorectal carcinoma.
    Chang W; Wu L; Cao F; Liu Y; Ma L; Wang M; Zhao D; Li P; Zhang Q; Tan X; Yu Y; Lou Z; Zhao J; Zhang H; Fu C; Cao G
    Clin Cancer Res; 2011 Sep; 17(17):5715-24. PubMed ID: 21771877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantibodies in prostate cancer.
    Rocco B; Djavan B; de Cobelli O
    N Engl J Med; 2005 Dec; 353(26):2815-7; author reply 2815-7. PubMed ID: 16382547
    [No Abstract]   [Full Text] [Related]  

  • 6. A novel multiplex assay combining autoantibodies plus PSA has potential implications for classification of prostate cancer from non-malignant cases.
    Xie C; Kim HJ; Haw JG; Kalbasi A; Gardner BK; Li G; Rao J; Chia D; Liong M; Punzalan RR; Marks LS; Pantuck AJ; de la Taille A; Wang G; Mukouyama H; Zeng G
    J Transl Med; 2011 Apr; 9():43. PubMed ID: 21504557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Profiling tumor-associated autoantibodies for the detection of colon cancer.
    Ran Y; Hu H; Zhou Z; Yu L; Sun L; Pan J; Liu J; Yang Z
    Clin Cancer Res; 2008 May; 14(9):2696-700. PubMed ID: 18451234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantibodies in prostate cancer.
    Tan EM; Koziol JA
    N Engl J Med; 2005 Dec; 353(26):2815-7; author reply 2815-7. PubMed ID: 16382071
    [No Abstract]   [Full Text] [Related]  

  • 9. Autoantibody Signatures Combined with Epstein-Barr Virus Capsid Antigen-IgA as a Biomarker Panel for the Detection of Nasopharyngeal Carcinoma.
    Peng YH; Xu YW; Huang LS; Zhai TT; Dai LH; Qiu SQ; Yang YS; Chen WZ; Zhang LQ; Li EM; Xu LY
    Cancer Prev Res (Phila); 2015 Aug; 8(8):729-36. PubMed ID: 25990085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoantibodies in prostate cancer.
    Kida Y
    N Engl J Med; 2005 Dec; 353(26):2815-7; author reply 2815-7. PubMed ID: 16382546
    [No Abstract]   [Full Text] [Related]  

  • 11. Tumor-associated autoantibody signature for the early detection of gastric cancer.
    Zayakin P; Ancāns G; Siliņa K; Meistere I; Kalniņa Z; Andrejeva D; Endzeliņš E; Ivanova L; Pismennaja A; Ruskule A; Doniņa S; Wex T; Malfertheiner P; Leja M; Linē A
    Int J Cancer; 2013 Jan; 132(1):137-47. PubMed ID: 22684876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantibodies in prostate cancer.
    Thorat MA; Badwe RA
    N Engl J Med; 2005 Dec; 353(26):2815-7; author reply 2815-7. PubMed ID: 16382548
    [No Abstract]   [Full Text] [Related]  

  • 13. Prostate-specific antigen and free prostate-specific antigen in the early detection of prostate cancer: do combination tests improve detection?
    Etzioni R; Falcon S; Gann PH; Kooperberg CL; Penson DF; Stampfer MJ
    Cancer Epidemiol Biomarkers Prev; 2004 Oct; 13(10):1640-5. PubMed ID: 15466981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case control study of sarcosine as an early prostate cancer detection biomarker.
    Ankerst DP; Liss M; Zapata D; Hoefler J; Thompson IM; Leach RJ
    BMC Urol; 2015 Oct; 15():99. PubMed ID: 26429735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate cancer-associated autoantibodies in serum against tumor-associated antigens as potential new biomarkers.
    Ummanni R; Duscharla D; Barett C; Venz S; Schlomm T; Heinzer H; Walther R; Bokemeyer C; Brümmendorf TH; Murthy PV; Balabanov S
    J Proteomics; 2015 Apr; 119():218-29. PubMed ID: 25724726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum Autoantibodies in Chronic Prostate Inflammation in Prostate Cancer Patients.
    Schlick B; Massoner P; Lueking A; Charoentong P; Blattner M; Schaefer G; Marquart K; Theek C; Amersdorfer P; Zielinski D; Kirchner M; Trajanoski Z; Rubin MA; Müllner S; Schulz-Knappe P; Klocker H
    PLoS One; 2016; 11(2):e0147739. PubMed ID: 26863016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoantibody profiles reveal ubiquilin 1 as a humoral immune response target in lung adenocarcinoma.
    Chen G; Wang X; Yu J; Varambally S; Yu J; Thomas DG; Lin MY; Vishnu P; Wang Z; Wang R; Fielhauer J; Ghosh D; Giordano TJ; Giacherio D; Chang AC; Orringer MB; El-Hefnawy T; Bigbee WL; Beer DG; Chinnaiyan AM
    Cancer Res; 2007 Apr; 67(7):3461-7. PubMed ID: 17409457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive properties of serum-prostate-specific antigen testing in a community-based setting.
    Jacobsen SJ; Bergstralh EJ; Guess HA; Katusic SK; Klee GG; Oesterling JE; Lieber MM
    Arch Intern Med; 1996 Nov; 156(21):2462-8. PubMed ID: 8944739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of novel peptide ligands modulating the enzyme activity of prostate-specific antigen.
    Leinonen J; Wu P; Koivunen E; Närvänen A; Stenman UH
    Scand J Clin Lab Invest Suppl; 2000; 233():59-64. PubMed ID: 11317943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoantibody against new gene expressed in prostate protein is traceable in prostate cancer patients.
    Mohsenzadegan M; Saebi F; Yazdani M; Abolhasani M; Saemi N; Jahanbani F; Farajollahi MM
    Biomark Med; 2018 Oct; 12(10):1125-1138. PubMed ID: 30191737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.